Aesthetic Surgery Journal
Aesthetic Surgery Journal An Analysis of Safety Data from Five Phase III Clinical Trials on the Use of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines Mark Rubin, MD; Jeffrey Dover, MD, FRCPC; Corey Maas, MD; and Mark Nestor, MD, PhD
Read moreArchives of Facial Plastic Surgery
Archives of Facial Plastic Surgery Determination of Shear Strength of Periosteum Attached to Bone With BioGlue Surgical Adhesive Douglas M. Sidle, MD; Corey S. Maas, MD
Read moreArchives of Facial Plastic Surgery
Archives of Facial Plastic Surgery Effect of Homeopathic Arnica montana on Bruising in Face-lifts Brook M. Seeley, MD; Andrew B. Denton, MD; Min S. Ahn, MD; Corey S. Maas, MD
Read moreArchives of Facial Plastic Surgery
Archives of Facial Plastic Surgery Use of BioGlue Surgical Adhesive for Brow Fixation in Endoscopic Browplasty Douglas M. Sidle, MD; Benjamin M. Loos, MD; Alexander L. Ramirez, MD; Sheldon S. Kabaker, MD; Corey S. Maas, MD
Read moreArchives of Facial Plastic Surgery
Archives of Facial Plastic Surgery A Validated Rating Scale for Hyperkinetic Facial Lines Eugene J. Kim, MD; Jay B. Reeck, MD; Corey S Maas, MD
Read moreNeuromodulators and Injectable Soft Tissue Substitutes
Chapter 28: Neuromodulators and Injectable Soft Tissue Substitutes Corey S. Maas MDTM FACS, 1,2 Kenneth C.Y. Yu, 3 Kristin Egan MD 1 1 Division of Facial Plastic Surgery, University of California at San Francisco, CA 2 The Maas ClinicTM, San Francisco, CA
Read moreSoft Tissue Fillers and Facial Plastic Surgery Practice
Chapter 11: Soft Tissue Fillers and Facial Plastic Surgery Practice Corey S. Maas, M.DTM, FACS & David Lewis, M.D.
Read moreBotulinum Toxins for Facial Wrinkles: Beyond Glabellar Lines
Authors: Steven H. Dayan, MD and Corey S. Maas, MD Manuscript developed by IntraMed Educational Group Draft Date: November 2, 2006 Data source: published literature; authors
Read more